[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100452922":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":24,"centralContacts":31,"locations":39,"responsibleParty":252,"collaborators":10,"id":256,"slug":257,"hasResults":258,"nctId":259,"briefTitle":260,"officialTitle":260,"acronym":261,"eligibilityCriteria":262,"healthyVolunteers":263,"sex":264,"minAge":265,"maxAge":10,"enrollmentInfo":266,"targetDuration":269,"studyType":270,"phases":10,"briefSummary":271,"conditions":272,"keywords":274,"overallStatus":42,"whyStopped":10,"lastUpdateSubmitDate":278,"lastUpdatePostDateStruct":279,"startDateStruct":282,"completionDateStruct":284,"leadSponsor":286,"locationsCount":287},{"fullName":5,"class":6},"University Hospital Tuebingen","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"RFC1",null,"Participants with genetically confirmed RFC1 repeat expansion disease (ORPHA: 504476; OMIM 102579) will be recruited. Target sample size for the RFC1 cohort is 100 participants.",[13],"Other: Clinical rating scale to measure ataxia disease severity and progression",{"label":15,"type":10,"description":16,"interventionNames":10},"Unrelated healthy controls","Unrelated healthy controls Healthy controls may undergo the same study procedures as the RFC1 cohort. Target sample size for the control cohort is 50.",[18],{"type":6,"name":19,"description":20,"armGroupLabels":21,"otherNames":22},"Clinical rating scale to measure ataxia disease severity and progression","SARA is a clinical scale developed by Schmitz-Hübsch et al which assesses a range of different impairments in cerebellar ataxia. The scale is made up of 8 items related to gait, stance, sitting, speech, finger-chase test, nose-finger test, fast alternating movements and heel-shin test.",[9],[23],"Scale for the Assessment and rating of Ataxia (SARA)",[25,29],{"name":26,"affiliation":27,"role":28},"Matthis Synofzik, Prof. Dr.","University Hospital Tübingen","PRINCIPAL_INVESTIGATOR",{"name":30,"affiliation":27,"role":28},"Andreas Traschütz, Dr. Dr.",[32,37],{"name":26,"role":33,"phone":34,"phoneExt":35,"email":36},"CONTACT","+49 7071 29","82060","matthis.synofzik@uni-tuebingen.de",{"name":30,"role":33,"phone":34,"phoneExt":35,"email":38},"andreas.traschuetz@uni-tuebingen.de",[40,69,94,113,136,153,173,192,213,230],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Department of Neuroscience, Central Clinical School, Monash University","RECRUITING","Melbourne","Victoria","3004","Australia","AU",{"type":49,"coordinates":50},"Point",[51,52],144.96332,-37.814,{"lat":52,"lon":51},[55,60,65,66,67],{"name":56,"role":33,"phone":57,"phoneExt":58,"email":59},"Ian Harding, PhD","+61 3 9905","9283","Ian.Harding@monash.edu",{"name":61,"role":33,"phone":62,"phoneExt":63,"email":64},"Adam Vogel, PhD",", +61 3 9035","5334","vogela@unimelb.edu.au",{"name":56,"role":28,"phone":10,"phoneExt":10,"email":10},{"name":61,"role":28,"phone":10,"phoneExt":10,"email":10},{"name":68,"role":28,"phone":10,"phoneExt":10,"email":10},"David Szmulewicz, MD, PhD",{"facility":70,"status":42,"city":71,"state":72,"zip":73,"country":74,"countryCode":75,"cosmosGeoPoint":76,"geoPoint":80,"contacts":81},"Department of Neurology, Ataxia Unit, Universidade Federal de São Paulo","São Paulo","State of São Paulo","04040-003","Brazil","BR",{"type":49,"coordinates":77},[78,79],-46.63611,-23.5475,{"lat":79,"lon":78},[82,87,91,92],{"name":83,"role":33,"phone":84,"phoneExt":85,"email":86},"José Luiz Pedroso, MD","+55 11","976449929","zeluizpedroso@yahoo.com.br",{"name":88,"role":33,"phone":84,"phoneExt":89,"email":90},"Paula Camila Alves, MD","948223643","paulacamila_alves@hotmail.com",{"name":83,"role":28,"phone":10,"phoneExt":10,"email":10},{"name":93,"role":28,"phone":10,"phoneExt":10,"email":10},"Orlando Graziani Povoas Barsottini, MD",{"facility":95,"status":42,"city":96,"state":96,"zip":97,"country":98,"countryCode":99,"cosmosGeoPoint":100,"geoPoint":104,"contacts":105},"Service de Neurologie, Hôpitaux Universitaires de Strasbourg","Strasbourg","67000","France","FR",{"type":49,"coordinates":101},[102,103],7.74553,48.58392,{"lat":103,"lon":102},[106,109,111],{"name":107,"role":33,"phone":10,"phoneExt":10,"email":108},"Thomas Wirth, Dr.","thomas.wirth@chru-strasbourg.fr",{"name":110,"role":28,"phone":10,"phoneExt":10,"email":10},"Mathieu Anheim, Prof.",{"name":107,"role":112,"phone":10,"phoneExt":10,"email":10},"SUB_INVESTIGATOR",{"facility":114,"status":42,"city":115,"state":116,"zip":117,"country":118,"countryCode":119,"cosmosGeoPoint":120,"geoPoint":124,"contacts":125},"Center for Neurology & Hertie-Institute for Clinical Brain Research, Dept. for Neurodegenerative Diseases","Tübingen","Baden-Wurttemberg","72076","Germany","DE",{"type":49,"coordinates":121},[122,123],9.05222,48.52266,{"lat":123,"lon":122},[126,130,134,135],{"name":127,"role":33,"phone":34,"phoneExt":128,"email":129},"Lisa Graf, MSc","85374","lisa.graf@med.uni-tuebingen.de",{"name":131,"role":33,"phone":34,"phoneExt":132,"email":133},"Doreen Müller","85353","doreen.mueller@med-uni-tuebingen.de",{"name":26,"role":28,"phone":10,"phoneExt":10,"email":10},{"name":30,"role":28,"phone":10,"phoneExt":10,"email":10},{"facility":137,"status":42,"city":138,"state":139,"zip":140,"country":118,"countryCode":119,"cosmosGeoPoint":141,"geoPoint":145,"contacts":146},"German Center for Neurodegenerative Diseases (DZNE)","Bonn","North Rhine-Westphalia","53127",{"type":49,"coordinates":142},[143,144],7.09549,50.73438,{"lat":144,"lon":143},[147,150,151],{"name":148,"role":33,"phone":10,"phoneExt":10,"email":149},"Jennifer Faber, Dr.","jennifer.faber@ukbonn.de",{"name":148,"role":28,"phone":10,"phoneExt":10,"email":10},{"name":152,"role":112,"phone":10,"phoneExt":10,"email":10},"Thomas Klockgether, Prof. Dr.",{"facility":154,"status":42,"city":155,"state":156,"zip":157,"country":118,"countryCode":119,"cosmosGeoPoint":158,"geoPoint":162,"contacts":163},"Department of Neurology University Hospital Schleswig Holstein","Lübeck","Schleswig-Holstein","23562",{"type":49,"coordinates":159},[160,161],10.68729,53.86893,{"lat":161,"lon":160},[164,169,171],{"name":165,"role":33,"phone":166,"phoneExt":167,"email":168},"Madita Grümmer","+49 451 500","43440","madita.gruemmer@neuro.uni-luebeck.de",{"name":170,"role":28,"phone":10,"phoneExt":10,"email":10},"Norbert Brüggemann, Prof. Dr.",{"name":172,"role":112,"phone":10,"phoneExt":10,"email":10},"Max Borsche, Dr.",{"facility":174,"status":42,"city":175,"state":176,"zip":177,"country":178,"countryCode":179,"cosmosGeoPoint":180,"geoPoint":184,"contacts":185},"Università degli Studi di Napoli 'Federico II', c\u002Fo AOU Federico II","Naples","Napoli","80131","Italy","IT",{"type":49,"coordinates":181},[182,183],14.26811,40.85216,{"lat":183,"lon":182},[186,189,190],{"name":187,"role":33,"phone":10,"phoneExt":10,"email":188},"Francesco Saccà, Prof.","francesco.sacca@unina.it",{"name":187,"role":28,"phone":10,"phoneExt":10,"email":10},{"name":191,"role":112,"phone":10,"phoneExt":10,"email":10},"Chiara Pane, Dr.",{"facility":193,"status":42,"city":194,"state":10,"zip":195,"country":178,"countryCode":179,"cosmosGeoPoint":196,"geoPoint":200,"contacts":201},"IRCCS Fondazione Stella Maris","Pisa","56128",{"type":49,"coordinates":197},[198,199],10.4036,43.70853,{"lat":199,"lon":198},[202,207,212],{"name":203,"role":33,"phone":204,"phoneExt":205,"email":206},"Filippo M. Santorelli, MD","+39 050","886275","filippo.santorelli@fsm.unipi.it",{"name":208,"role":33,"phone":209,"phoneExt":210,"email":211},"Ivana Ricca, MD","39 050","886311","ivanaricca.fsm@gmail.com",{"name":203,"role":28,"phone":10,"phoneExt":10,"email":10},{"facility":214,"status":42,"city":215,"state":10,"zip":216,"country":217,"countryCode":218,"cosmosGeoPoint":219,"geoPoint":223,"contacts":224},"Centre of Brain Research Neurogenetics Research Clinic, University of Auckland","Auckland","1142","New Zealand","NZ",{"type":49,"coordinates":220},[221,222],174.76349,-36.84853,{"lat":222,"lon":221},[225,228],{"name":226,"role":33,"phone":10,"phoneExt":10,"email":227},"Ashleigh O'Mara Baker","cbr.nrc@auckland.ac.nz",{"name":229,"role":28,"phone":10,"phoneExt":10,"email":10},"Richard Roxburgh, Prof.",{"facility":231,"status":42,"city":232,"state":10,"zip":233,"country":234,"countryCode":10,"cosmosGeoPoint":235,"geoPoint":239,"contacts":240},"Koç University Hospital, KUTTAM-NDAL","Istanbul","34010","Turkey (Türkiye)",{"type":49,"coordinates":236},[237,238],28.94966,41.01384,{"lat":238,"lon":237},[241,246,250,251],{"name":242,"role":33,"phone":243,"phoneExt":244,"email":245},"Nazli BAŞAK, PhD","+90-850","250825023811","nbasak@ku.edu.tr",{"name":247,"role":33,"phone":243,"phoneExt":248,"email":249},"Atay Vural, MD, PhD","850 250 8250","atayvural@ku.edu.tr",{"name":242,"role":28,"phone":10,"phoneExt":10,"email":10},{"name":247,"role":28,"phone":10,"phoneExt":10,"email":10},{"type":253,"investigatorFullName":254,"investigatorTitle":255,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Prof. Dr. Matthis Synofzik","Principal Investigator, Leading Consultant","100452922","rfc1-natural-history-study-100452922",false,"NCT05177809","RFC1 Natural History Study","RFC1-NHS","Inclusion Criteria:\n\n* RFC1: genetic diagnosis of bi-allelic pathogenic repeat expansions in RFC1\n* Unrelated healthy controls: no signs or history of neurological or psychiatric disease AND\n* Written informed consent AND\n* Participants are willing and able to comply with study procedures\n\nExclusion Criteria:\n\n* RFC1: Missing informed consent\n* Controls: evidence of neuropathy, neurodegenerative disease, or movement disorder; inability to give informed consent",true,"ALL","18 Years",{"count":267,"type":268},150,"ESTIMATED","24 Months","OBSERVATIONAL","This international, multi-center, multi-modal and prospective observational study aims to determine the phenotypic spectrum and the natural progression of the RFC1 repeat expansion disease, and to seek and validate digital, imaging, and molecular biomarkers that aid in diagnosis and serve as outcome measures in future clinical trials of this novel, but frequent ataxia with late adult-onset.",[273],"Ataxia",[9,275,276,277],"CANVAS","Natural History Study","Biomarker","2026-03-30",{"date":280,"type":281},"2026-03-31","ACTUAL",{"date":283,"type":281},"2021-12-14",{"date":285,"type":268},"2026-12",{"name":254,"class":6},10]